United Therapeutics CEO Martine A. Rothblatt disposes of 9,500 shares worth USD 4.76 million
UTHR•Rothblatt exercises options and sells shares
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $117.76 on Sept. 15.
- The same trust sold 9,500 shares in multiple trades at weighted-average prices from $499.77 to $504.57 on Sept. 15.
- Trust holdings ended at 324,443 shares of common stock.
